Current retail value sales growth of dermatologicals will be slower in Lithuania during 2021, when compared to the rest of the review period. Nonetheless, vaginal antifungals is the most dynamic dermatologicals category in 2021 and sees robust retail value sales growth despite growth being slower than for the rest of the review period.
The COVID-19 pandemic provided a boost to retail value sales growth of topical germicidals/antiseptics during the start of the pandemic in 2020, as worried consumers sought to decrease their risk of catching the virus by frequent handwashing. The Benu Pharmacy chain reported that sales were running at 50 times their usual level during March and demand for these products were further boosted by the second wave of the pandemic that hit Lithuania in the autumn.
Similar to other OTC categories in Lithuania, dermatologicals is characterised by a high level of inertia. Value sales are dominated by three international players – Bayer AG, Polichem SA and Schülke & Mayr GmbH – with high-profile brands, leaving limited room for local competitors.
As a result of many consumers moving less during the pandemic, there has been an increase in overweight people as well as digestive problems which gives rise to haemorrhoids. Consequently, current retail value sales of haemorrhoid treatments see an increase in 2021.
During the lockdowns, as a result of the pandemic during 2020 and 2021, sales of antiparasitics/lice (head and body) treatments see decreased growth in constant retail value sales as schools are closed for much of the time. This trend is likely to continue during the forecast period.
As people’s psychological health improves during the forecast period thanks to the pandemic coming to an end, many people are likely to be less stressed and have fewer problems with hair loss. Consequently, constant retail values sales growth of hair loss treatments and medicated shampoos is anticipated to decelerate during the forecast period.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in Lithuania with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Medicated Skin Care industry in Lithuania, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Medicated Skin Care
This report originates from Passport, our Medicated Skin Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page